GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » Cash Conversion Cycle

SANUWAVE Health (SANUWAVE Health) Cash Conversion Cycle : -77.00 (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is SANUWAVE Health Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

SANUWAVE Health's Days Sales Outstanding for the three months ended in Dec. 2023 was 42.7.
SANUWAVE Health's Days Inventory for the three months ended in Dec. 2023 was 98.56.
SANUWAVE Health's Days Payable for the three months ended in Dec. 2023 was 218.26.
Therefore, SANUWAVE Health's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was -77.00.


SANUWAVE Health Cash Conversion Cycle Historical Data

The historical data trend for SANUWAVE Health's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SANUWAVE Health Cash Conversion Cycle Chart

SANUWAVE Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only -666.37 -266.60 -229.63 -356.87 -124.39

SANUWAVE Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -221.70 -194.70 -252.95 -166.24 -77.00

Competitive Comparison of SANUWAVE Health's Cash Conversion Cycle

For the Medical Devices subindustry, SANUWAVE Health's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SANUWAVE Health's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's Cash Conversion Cycle falls into.



SANUWAVE Health Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

SANUWAVE Health's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=65.7+115.49-305.58
=-124.39

SANUWAVE Health's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=42.7+98.56-218.26
=-77.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SANUWAVE Health  (OTCPK:SNWV) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


SANUWAVE Health Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


SANUWAVE Health (SANUWAVE Health) Business Description

Traded in Other Exchanges
N/A
Address
11495 Valley View Road, Eden Prairie, MN, USA, 30024
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Executives
Andrew Walko officer: President 11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
James E Besser director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p. director, other: Director by Deputization MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank director 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price director 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh officer: President 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii 10 percent owner 200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski director 99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc. director 3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom officer: Interim CFO 11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli director, officer: Chief Executive Officer 510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins officer: Chief Financial Officer 11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino director PO BOX 376, LOBBY L., ANN ARBOR MI 48105